Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies.

Astradsson A, Jenkins BG, Choi JK, Hallett PJ, Levesque MA, McDowell JS, Brownell AL, Spealman RD, Isacson O.

Neurobiol Dis. 2009 Sep;35(3):348-51. doi: 10.1016/j.nbd.2009.05.018.

2.
3.

Translating A2A antagonist KW6002 from animal models to parkinsonian patients.

Chase TN, Bibbiani F, Bara-Jimenez W, Dimitrova T, Oh-Lee JD.

Neurology. 2003 Dec 9;61(11 Suppl 6):S107-11. Review.

PMID:
14663022
4.

Avoidance of dyskinesia: preclinical evidence for continuous dopaminergic stimulation.

Jenner P.

Neurology. 2004 Jan 13;62(1 Suppl 1):S47-55. Review.

PMID:
14718680

Supplemental Content

Support Center